Plant ID: NPO29027
Plant Latin Name: Khaya grandifoliola
Taxonomy Genus: Khaya
Taxonomy Family: Meliaceae
NCBI TaxonomyDB:
859838
Plant-of-the-World-Online:
n.a.
Nigeria
GPBAR1; | |
RECQL; ALDH1A1; HSD17B2; | |
CA7; CA4; CA12; | |
NR1H4; | |
HIF1A; | |
NPC1; MAPT; RAB9A; LMNA; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.357E-08 | 2.954E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 6.716E-08 | 7.312E-04 | CYP2C19, CYP2C9, CYP3A4, HSD17B2, NPC1, NR1H4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.487E-07 | 1.079E-03 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 3.070E-07 | 1.671E-03 | CA12, CA4, CA7 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 2.459E-06 | 6.982E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 2.459E-06 | 6.982E-03 | GPBAR1, NR1H4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.759E-06 | 8.234E-03 | CA12, CA4, CA7 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 3.993E-06 | 8.234E-03 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 4.916E-06 | 8.234E-03 | CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 9.408E-06 | 1.366E-02 | CYP2C19, CYP2C9, CYP3A4 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 5.383E-05 | 4.689E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 6.359E-05 | 4.975E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 4.130E-07 | 1.280E-05 | CA12, CA4, CA7 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.204E-06 | 3.416E-05 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.582E-05 | 2.395E-04 | CYP2C9, ALDH1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.090E-05 | 2.395E-04 | CYP2C9, CYP3A4, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.185E-05 | 3.215E-04 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.401E-03 | 6.205E-03 | CYP2C9, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.227E-03 | 6.205E-03 | HSD17B2, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 3.932E-03 | 1.219E-02 | CYP2C9, HSD17B2, ALDH1A1, CYP2C19, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.936E-03 | 6.668E-03 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.832E-03 | 6.668E-03 | NR1H4, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |